Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Effect of Antihypertensive Medication Use on Fall Risk
NCT07099677Recruiting
- Sponsor
- Bolu Abant Izzet Baysal University
- Start
- Aug 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of carvedilol in hypertension (HTN) (3 arms), sponsored by Bolu Abant Izzet Baysal University. Primary endpoint: Fall Risk Score at 4 weeks. Started Aug 2025; status: recruiting.
02
Drugs
carvedilol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT07099677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07099677.